vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.

Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $40.7M, roughly 1.9× PETMED EXPRESS INC). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -178.3%, a 152.3% gap on every dollar of revenue. On growth, Repay Holdings Corp posted the faster year-over-year revenue change (0.4% vs -23.3%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-9.2M). Over the past eight quarters, Repay Holdings Corp's revenue compounded faster (-1.3% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.

PETS vs RPAY — Head-to-Head

Bigger by revenue
RPAY
RPAY
1.9× larger
RPAY
$78.6M
$40.7M
PETS
Growing faster (revenue YoY)
RPAY
RPAY
+23.7% gap
RPAY
0.4%
-23.3%
PETS
Higher net margin
PETS
PETS
152.3% more per $
PETS
-26.0%
-178.3%
RPAY
More free cash flow
RPAY
RPAY
$32.5M more FCF
RPAY
$23.2M
$-9.2M
PETS
Faster 2-yr revenue CAGR
RPAY
RPAY
Annualised
RPAY
-1.3%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
RPAY
RPAY
Revenue
$40.7M
$78.6M
Net Profit
$-10.6M
$-140.1M
Gross Margin
23.3%
74.2%
Operating Margin
-25.7%
-182.2%
Net Margin
-26.0%
-178.3%
Revenue YoY
-23.3%
0.4%
Net Profit YoY
-1392.6%
-3304.1%
EPS (diluted)
$-0.50
$-1.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
RPAY
RPAY
Q4 25
$40.7M
$78.6M
Q3 25
$44.4M
$77.7M
Q2 25
$51.2M
$75.6M
Q1 25
$50.8M
$77.3M
Q4 24
$52.0M
$78.3M
Q3 24
$58.0M
$79.1M
Q2 24
$66.2M
$74.9M
Q1 24
$65.1M
$80.7M
Net Profit
PETS
PETS
RPAY
RPAY
Q4 25
$-10.6M
$-140.1M
Q3 25
$-8.5M
$-6.4M
Q2 25
$-34.2M
$-102.3M
Q1 25
$-11.6M
$-7.9M
Q4 24
$-707.0K
$-4.1M
Q3 24
$2.3M
$3.2M
Q2 24
$3.8M
$-4.1M
Q1 24
$-5.0M
$-5.2M
Gross Margin
PETS
PETS
RPAY
RPAY
Q4 25
23.3%
74.2%
Q3 25
28.0%
74.4%
Q2 25
28.1%
75.7%
Q1 25
29.9%
75.9%
Q4 24
31.0%
76.3%
Q3 24
32.3%
77.8%
Q2 24
28.8%
78.2%
Q1 24
29.3%
76.2%
Operating Margin
PETS
PETS
RPAY
RPAY
Q4 25
-25.7%
-182.2%
Q3 25
-18.9%
-3.9%
Q2 25
-66.7%
-138.7%
Q1 25
-11.9%
-4.7%
Q4 24
-0.9%
-1.5%
Q3 24
1.0%
-0.9%
Q2 24
6.6%
-4.6%
Q1 24
-5.9%
-3.1%
Net Margin
PETS
PETS
RPAY
RPAY
Q4 25
-26.0%
-178.3%
Q3 25
-19.2%
-8.3%
Q2 25
-66.7%
-135.2%
Q1 25
-22.9%
-10.3%
Q4 24
-1.4%
-5.3%
Q3 24
4.0%
4.1%
Q2 24
5.7%
-5.4%
Q1 24
-7.7%
-6.5%
EPS (diluted)
PETS
PETS
RPAY
RPAY
Q4 25
$-0.50
$-1.68
Q3 25
$-0.41
$-0.08
Q2 25
$-1.65
$-1.15
Q1 25
$-0.56
$-0.09
Q4 24
$-0.03
$-0.04
Q3 24
$0.11
$0.03
Q2 24
$0.18
$-0.04
Q1 24
$-0.24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
RPAY
RPAY
Cash + ST InvestmentsLiquidity on hand
$26.9M
$115.7M
Total DebtLower is stronger
$280.1M
Stockholders' EquityBook value
$32.8M
$484.4M
Total Assets
$88.0M
$1.2B
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
RPAY
RPAY
Q4 25
$26.9M
$115.7M
Q3 25
$36.1M
$95.7M
Q2 25
$41.1M
$162.6M
Q1 25
$54.7M
$165.5M
Q4 24
$50.1M
$189.5M
Q3 24
$52.0M
$168.7M
Q2 24
$46.0M
$147.1M
Q1 24
$55.3M
$128.3M
Total Debt
PETS
PETS
RPAY
RPAY
Q4 25
$280.1M
Q3 25
$279.5M
Q2 25
$279.0M
Q1 25
$497.6M
Q4 24
$496.8M
Q3 24
$496.2M
Q2 24
$435.6M
Q1 24
$434.9M
Stockholders' Equity
PETS
PETS
RPAY
RPAY
Q4 25
$32.8M
$484.4M
Q3 25
$43.1M
$616.9M
Q2 25
$51.5M
$633.7M
Q1 25
$85.1M
$755.7M
Q4 24
$96.2M
$761.3M
Q3 24
$96.4M
$754.7M
Q2 24
$93.5M
$815.4M
Q1 24
$96.7M
$813.8M
Total Assets
PETS
PETS
RPAY
RPAY
Q4 25
$88.0M
$1.2B
Q3 25
$100.3M
$1.3B
Q2 25
$109.8M
$1.4B
Q1 25
$148.7M
$1.5B
Q4 24
$144.8M
$1.6B
Q3 24
$146.0M
$1.6B
Q2 24
$152.7M
$1.5B
Q1 24
$169.9M
$1.5B
Debt / Equity
PETS
PETS
RPAY
RPAY
Q4 25
0.58×
Q3 25
0.45×
Q2 25
0.44×
Q1 25
0.66×
Q4 24
0.65×
Q3 24
0.66×
Q2 24
0.53×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
RPAY
RPAY
Operating Cash FlowLast quarter
$-9.2M
$23.3M
Free Cash FlowOCF − Capex
$-9.2M
$23.2M
FCF MarginFCF / Revenue
-22.7%
29.6%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$90.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
RPAY
RPAY
Q4 25
$-9.2M
$23.3M
Q3 25
$-2.2M
$32.2M
Q2 25
$-12.3M
$33.1M
Q1 25
$7.0M
$2.5M
Q4 24
$-1.2M
$34.3M
Q3 24
$7.4M
$60.1M
Q2 24
$-8.5M
$31.0M
Q1 24
$7.1M
$24.8M
Free Cash Flow
PETS
PETS
RPAY
RPAY
Q4 25
$-9.2M
$23.2M
Q3 25
$-4.8M
$32.1M
Q2 25
$-13.6M
$33.0M
Q1 25
$4.6M
$2.4M
Q4 24
$-1.9M
$34.0M
Q3 24
$6.1M
$59.8M
Q2 24
$-9.2M
$30.5M
Q1 24
$5.9M
$24.7M
FCF Margin
PETS
PETS
RPAY
RPAY
Q4 25
-22.7%
29.6%
Q3 25
-10.8%
41.3%
Q2 25
-26.5%
43.6%
Q1 25
9.1%
3.0%
Q4 24
-3.7%
43.5%
Q3 24
10.6%
75.6%
Q2 24
-13.9%
40.7%
Q1 24
9.0%
30.6%
Capex Intensity
PETS
PETS
RPAY
RPAY
Q4 25
0.1%
0.1%
Q3 25
5.9%
0.2%
Q2 25
2.5%
0.1%
Q1 25
4.7%
0.2%
Q4 24
1.5%
0.3%
Q3 24
2.2%
0.3%
Q2 24
1.0%
0.6%
Q1 24
1.9%
0.1%
Cash Conversion
PETS
PETS
RPAY
RPAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
18.52×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

RPAY
RPAY

Sales Channel Directly To Consumer$69.4M88%
Other$6.8M9%
Sales Channel Through Intermediary$2.3M3%

Related Comparisons